Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

The Cochrane Database of Systematic Reviews has compared the long-term results from semaglutide (Ozempic, Wegovy) and ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

A groundbreaking study has compared the three top weight loss medications on the market, which has produced some surprising ...

This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...

Peptide medications require a prescription and are intended for long-term use with a balanced diet and exercise. Wegovy and Saxenda can help reduce appetite and increase feelings of fullness to ...

There are three main types of injectable weight loss drugs approved by the Food and Drug Administration (FDA): semaglutide, liraglutide and tirzepatide. These are administered either daily or weekly ...

A MAJOR review has pitted three blockbuster fat jabs against each other – comparing weight lost and how long users were able ...

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

Weight-loss injections, like Wegovy and Saxenda, are available on the NHS, and if they are prescribed alongside a reduced-calorie diet, increased physical activity, and behavioural support, after a ...

Here are six new shortages and discontinuations for April, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in ...